Your search returned 18 results.

Results
	1.	Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer. [Review] MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard PMID: 23186979 Year: 2013 Citation: Endocrine Practice. 19(1):139-48, 2013 Jan-Feb. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.4158/EP12244.RA Add to cart (remove)
	2.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in the identification of metastasis in differentiated thyroid cancer with 131I planar whole-body imaging and 124I PET.[Erratum appears in J Nucl Med. 2012 May;53(5):830] MedStar authors: Atkins, Frank B Burman, Kenneth D Chennupati, Shyam P Kharazi, Pejman Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Van Nostrand, Douglas Wartofsky, Leonard PMID: 22315442 Year: 2012 Citation: Journal of Nuclear Medicine. 53(3):359-62, 2012 Mar. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman KD, Chennupati SP, Kharazi P, Khorjekar GR, Mete M, Moreau S, O'Neil J, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.2967/jnumed.111.096016 Add to cart (remove)
	3.	Treatment of HER2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25970056 Year: 2015 Citation: New England Journal of Medicine. 372(20):1964-5, 2015 May 14. Institution: Washington Cancer Institute Medline publication type: Comment Letter Form of publication: Journal Article All authors: Baselga J, Clark E, Swain SM DOI: http://dx.doi.org/10.1056/NEJMc1503446 Add to cart (remove)
	4.	Evolution of Treatments for Peritoneal Metastases From Colorectal Cancer. MedStar authors: Sugarbaker, Paul H PMID: 25897165 Year: 2015 Citation: Journal of Clinical Oncology. 33(18):2122-3, 2015 Jun 20. Institution: MedStar Washington Hospital Center Department: Surgery/General Surgery Medline publication type: Letter Form of publication: Journal Article All authors: O'Dwyer S, Sugarbaker PH, Verwaal VJ DOI: http://dx.doi.org/10.1200/JCO.2015.61.3802 Add to cart (remove)
	5.	Laparoscopy technique in the setting of peritoneal metastases to avoid port site relapse. [Review] MedStar authors: Sugarbaker, Paul H PMID: 33773282 Year: 2021 Citation: Surgical Oncology. 37:101543, 2021 Jun. Institution: Washington Cancer Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Craus-Miguel A, Morales-Soriano R, Pineno Flores C, Segura-Sampedro JJ, Sugarbaker PH DOI: https://dx.doi.org/10.1016/j.suronc.2021.101543 Add to cart (remove)
	6.	Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report. MedStar authors: Sackstein, Paul Zaemes, Jacob PMID: 34330765 Year: 2021 Citation: Journal for Immunotherapy of Cancer. 9(7), 2021 07. Department: Internal Medicine Residency MedStar Georgetown University Hospital Medline publication type: Journal Article Form of publication: Journal Article All authors: Kim C, Sackstein P, Zaemes J DOI: https://dx.doi.org/10.1136/jitc-2021-002855 Add to cart (remove)
	7.	<sup>18</sup>F-FDG-PET SUV AS A PROGNOSTIC MARKER OF INCREASING SIZE IN THYROID CANCER TUMORS. MedStar authors: Bikas, Athanasios Burman, Kenneth D Desale, Sameer Garcia, Carlos Singh, Ishita Wartofsky, Leonard PMID: 27849386 Year: 2017 Citation: Endocrine Practice. 23(2):182-189, 2017 Feb Institution: MedStar Heart & Vascular Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bikas A, Burman KD, Desale S, Garcia CA, Singh I, Wartofsky L DOI: https://dx.doi.org/10.4158/EP161390.OR Add to cart (remove)
	8.	Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin. MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard PMID: 22313411 Citation: Thyroid. 22(3):310-7, 2012 Mar. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Comparative Study Journal Article Form of publication: Journal Article All authors: Burman KD, Jonklaas J, Klubo-Gwiezdzinska J, Mete M, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2011.0235 Add to cart (remove)
	9.	Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >= 50. MedStar authors: Rao, Suman PMID: 33872070 Year: 2021 Citation: Journal of Clinical Oncology. 39(21):2339-2349, 2021 07 20. Institution: MedStar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, Jensen E, Leal TA, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riess JW, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhao B DOI: https://dx.doi.org/10.1200/JCO.21.00174 Add to cart (remove)
	10.	Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report. MedStar authors: Atkins, Michael Benjamin PMID: 25003536 Year: 2014 Citation: Melanoma Research. 24(5):509-11, 2014 Oct. Institution: Washington Cancer Institute Form of publication: Journal Article All authors: Al-Refaie W, Atkins MB, Parks K, Rapisuwon S DOI: http://dx.doi.org/10.1097/CMR.0000000000000102 Add to cart (remove)
	11.	Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA). MedStar authors: Swain, Sandra M PMID: 24129974 Year: 2013 Citation: Breast Cancer Research & Treatment. 142(1):89-99, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Clark E, Knott A, Miles D, Ross G, Semiglazov V, Sunpaweravong P, Swain SM DOI: http://dx.doi.org/10.1007/s10549-013-2710-z Add to cart (remove)
	12.	Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III study. MedStar authors: Swain, Sandra M PMID: 23475636 Year: 2013 Citation: Oncologist. 18(3):257-64, 2013. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Amadori D, Baselga J, Benyunes MC, Clark E, Cortes J, Ewer MS, Knott A, Miles D, Ross G, Swain SM DOI: http://dx.doi.org/10.1634/theoncologist.2012-0448 Add to cart (remove)
	13.	The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 24885258 Year: 2014 Citation: BMC Cancer. 14:307, 2014. Institution: Washington Cancer Institute Medline publication type: Clinical Trial Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Beattie M, Hurvitz S, Jahanzeb M, Kaufman PA, Lai C, Masaquel A, Mason G, O'Shaughnessy J, Rugo HS, Swain S, Tripathy D, Yoo B DOI: http://dx.doi.org/10.1186/1471-2407-14-307 Add to cart (remove)
	14.	Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25332247 Year: 2014 Citation: Journal of Clinical Oncology. 32(33):3753-61, 2014 Nov 20. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Kiermaier A, Ross G, Swain SM DOI: http://dx.doi.org/10.1200/JCO.2013.54.5384 Add to cart (remove)
	15.	SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. MedStar authors: Shara, Nawar M PMID: 31878938 Year: 2019 Citation: Journal of Translational Medicine. 17(1):429, 2019 12 26. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Baste N, Clayburgh D, Cohen EEW, Fountzilas G, Fujii T, Khaliq A, Kim ES, Lin D, Lipworth L, Mehlhorn H, Melillo G, Pai SI, Resteghini C, Shara N, Shire N, Stokes M, Twumasi-Ankrah P, Wang H, Wildsmith S, Zhang J DOI: https://dx.doi.org/10.1186/s12967-019-02182-1 Add to cart (remove)
	16.	Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 23868905 Year: 2013 Citation: Annals of Oncology. 24(10):2630-5, 2013 Oct. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Clark E, Cortes J, Im SA, Im YH, Knott A, Pivot X, Ross G, Swain SM DOI: http://dx.doi.org/10.1093/annonc/mdt274 Add to cart (remove)
	17.	Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. MedStar authors: Swain, Sandra M PMID: 25693012 Year: 2015 Citation: New England Journal of Medicine. 372(8):724-34, 2015 Feb 19. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, CLEOPATRA Study Group, Cortes J, Ferrero JM, Heeson S, Kim SB, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1056/NEJMoa1413513 Add to cart (remove)
	18.	Absence of pharmacokinetic drug-drug interaction of pertuzumab with trastuzumab and docetaxel. MedStar authors: Swain, Sandra M PMID: 23969513 Year: 2013 Citation: Anti-Cancer Drugs. 24(10):1084-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Brewster M, Cortes J, Garg A, Grincuka E, Hauschild M, Kudaba I, Lum BL, Marier JF, Masuda N, McNally V, Nijem I, Patel T, Ross G, Swain SM, Trinh MM, Visich J DOI: http://dx.doi.org/10.1097/CAD.0000000000000016 Add to cart (remove)

Powered by Koha